Insider Trading Activity Edwards Lifesciences Corporation – CEO Sold 32,900 shares of Stock

Insider Trading Activity For Edwards Lifesciences Corporation

Michael A. Mussallem , CEO of Edwards Lifesciences Corporation reportedly Sold 32,900 shares of the company’s stock at an average price of 106.86 for a total transaction amount of $3,515,694.00 SEC Form

Insider Trading History For Edwards Lifesciences Corporation

On 8/9/2012 Michael A Mussallem, CEO, sold 35,000 with an average share price of $98.69 per share and the total transaction amounting to $3,454,150.00.View SEC Filing

On 10/4/2012 Donald E Bobo Jr, VP, sold 11,530 with an average share price of $110.14 per share and the total transaction amounting to $1,269,914.20.View SEC Filing

On 10/5/2012 Huimin Wang, VP, sold 6,250 with an average share price of $109.88 per share and the total transaction amounting to $686,750.00.View SEC Filing

On 3/13/2013 John H Kehl Jr, VP, sold 12,500 with an average share price of $87.75 per share and the total transaction amounting to $1,096,875.00.View SEC Filing

On 4/10/2013 Michael A Mussallem, CEO, sold 35,000 with an average share price of $83.37 per share and the total transaction amounting to $2,917,950.00.View SEC Filing

On 4/26/2013 Schack Wesley W Von, Director, bought 2,000 with an average share price of $64.95 per share and the total transaction amounting to $129,900.00.View SEC Filing

On 5/1/2013 John H Kehl Jr, VP, sold 12,500 with an average share price of $62.72 per share and the total transaction amounting to $784,000.00.View SEC Filing

Analyst Ratings For Edwards Lifesciences Corporation
These are 0 Sell Ratings, 5 Hold Ratings, 15 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for Edwards Lifesciences Corporation is Buy (Score: 2.81) with a consensus target price of $124.95 , a potential (14.09% upside)

Analyst Ratings History For Edwards Lifesciences Corporation

• On 1/4/2016 Sterne Agee CRT Boost Price Target of rating Buy with a price target of $90.00 to $92.00
• On 3/17/2016 Nomura Initiated Coverage of rating Buy with a price target of $101.00
• On 6/21/2016 Piper Jaffray Companies Reiterated Rating Overweight with a price target of $123.00
• On 7/27/2016 Citigroup Inc. Boost Price Target of rating Sell with a price target of $86.00 to $94.00
• On 9/11/2016 Wells Fargo & Company Reiterated Rating Buy
• On 12/1/2016 J P Morgan Chase & Co Set Price Target of rating Buy with a price target of $120.00
• On 12/10/2016 JMP Securities Reiterated Rating Equal Weight with a price target of $130.00

Recent Trading Activity for Edwards Lifesciences Corporation
Shares of Edwards Lifesciences Corporation closed the previous trading session at with shares trading hands.